High glucose conditions suppress the function of bone marrow-derived endothelial progenitor cells via inhibition of the eNOS-caveolin-1 complex

Molecular Medicine Reports

Volumn 5, Issue 2, 2012, Pages 341-346

  Cao, Chunli ^a   Zhang, Hongkun ^b   Gong, Li ^a   He, Yunjun ^b   Zhang, Nan ^a  

^a ZHEJIANG UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY   (China)

Author keywords

Diabetes mellitus; Endothelial progenitor cells; eNOS caveolin 1 complex; High glucose

Indexed keywords

CAVEOLIN 1; CD133 ANTIGEN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; FLUORESCEIN ISOTHIOCYANATE; GLUCOSE; LECTIN; LOW DENSITY LIPOPROTEIN; MESSENGER RNA; NITRIC OXIDE; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; BONE MARROW; BONE MARROW DERIVED ENDOTHELIAL PROGENITOR CELL; CELL ADHESION; CELL CULTURE; CELL DIFFERENTIATION; CELL FUNCTION; CELL GROWTH; CELL MIGRATION; CELL PROLIFERATION; COMPLEX FORMATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CULTURE MEDIUM; ENDOTHELIAL PROGENITOR CELL; FLUORESCENCE MICROSCOPY; GENE EXPRESSION; GROWTH INHIBITION; HEMATOPOIETIC STEM CELL; IMMUNOFLUORESCENCE TEST; IN VITRO STUDY; LECTIN BINDING; MONONUCLEAR CELL; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS; PROTEIN TRANSPORT;

ANIMALS; BONE MARROW CELLS; CAVEOLIN 1; CELL MOVEMENT; CELL PROLIFERATION; ENZYME INHIBITORS; GLUCOSE; MALE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; STEM CELLS;

RATTUS;

EID: 84862957691     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2011.644     Document Type: Article

References (20)

1. Asahara T, Murohara T, Sullivan A, et al: Isolation of putative progenitor endothelial cells for angiogenesis. Science 275: 964-967, 1997. (Pubitemid 27087709)
2. Ruiter MS, van Golde JM, Schaper NC, et al: Diabetes impairs arteriogenesis in the peripheral circulation: review of molecular mechanisms. Clin Sci 119: 225-238, 2010.
3. Albiero M, Menegazzo L, Boscaro E, et al: Defective recruitment, survival and proliferation of bone marrow-derived progenitor cells at sites of delayed diabetic wound healing in mice. Diabetologia 54: 945-953, 2011.
4. Pan YM, Yao YZ, Zhu ZH, et al: Caveolin-1 is important for nitric oxide-mediated angiogenesis in fibrin gels with human umbilical vein endothelial cells. Acta Pharmacol Sin 27: 1567-1574, 2006. (Pubitemid 44813893)
5. Feron O and Balligand JL: Caveolins and the regulation of endothelial nitric oxide synthase in the heart. Cardiovasc Res 69: 788-797, 2006. (Pubitemid 43227977)
6. Kahler CM, Wechselberger J, Hilbe W, et al: Peripheral infusion of rat bone marrow derived endothelial progenitor cells leads to homing in acute lung injury. Respir Res 8: 50, 2007.
7. + endothelial progenitor cell subpopulation with potent vasoregenerative capacities. Circ Res 98: e20-e25, 2006.
8. Benameur T, Tual-Chalot S, Andriantsitohaina R, et al: PPARα is essential for microparticle-induced differentiation of mouse bone marrow-derived endothelial progenitor cells and angiogenesis. PLoS One 5: e12392, 2010.
9. Ii M, Takenaka H, Asai J, et al: Endothelial progenitor thrombospondin- 1 mediates diabetes-induced delay in reendothelialization following arterial injury. Circ Res 98: 697-704, 2006.
10. Naruse K, Hamada Y, Nakashima E, et al: Therapeutic neovascularization using cord blood-derived endothelial progenitor cells for diabetic neuropathy. Diabetes 54: 1823-1828, 2005. Erratum in: Diabetes 55: 1534, 2006. (Pubitemid 40770773)
11. Zeng R, Chen YC, Zeng Z, et al: Effect of mini-tyrosyl-tRNA synthetase/mini-tryptophanyl-tRNA synthetase on ischemic angiogenesis in rats: proliferation and migration of endothelial cells. Heart Vessels 26: 69-80, 2011.
12. Takeshita S and Isner JM: Peripheral angiogenesis: therapeutic angiogenesis for peripheral vascular occlusive disease. Curr Interv Cardiol Rep 1: 147-156, 1999.
13. Chang HW, Leu S, Sun CK, et al: Level and value of circulating endothelial progenitor cells in patients with acute myocardial infarction undergoing primary coronary angioplasty: in vivo and in vitro studies. Transl Res 156: 251-263, 2010.
14. Comerota AJ, Link A, Douville J, et al: Upper extremity ischemia treated with tissue repair cells from adult bone marrow. J Vasc Surg 52: 723-729, 2010.
15. Capla JM, Grogan RH, Callaghan MJ, et al: Diabetes impairs endothelial progenitor cell-mediated blood vessel formation in response to hypoxia. Plast Reconstr Surg 119: 59-70, 2007. (Pubitemid 46360247)
16. McGinn S, Saad S, Poronnik P and Pollock CA: High glucose-mediated effects on endothelial cell proliferation occur via p38 MAP kinase. Am J Physiol Endocrinol Metab 285: E708-E717, 2003. (Pubitemid 37176421)
17. Kuki S, Imanishi T, Kobayashi K, et al: Hyperglycemia accelerated endothelial progenitor cell senescence via the activation of p38 mitogen-activated protein kinase. Circ J 70: 1076-1081, 2006. (Pubitemid 44161749)
18. Dranka BP, Hill BG and Darley-Usmar VM: Mitochondrial reserve capacity in endothelial cells: the impact of nitric oxide and reactive oxygen species. Free Radic Biol Med 48: 905-914, 2010.
19. Wunderlich C, Schober K, Lange SA, et al: Disruption of caveolin-1 leads to enhanced nitrosative stress and severe systolic and diastolic heart failure. Biochem Biophys Res Commun 340: 702-708, 2006. (Pubitemid 43021803)
20. Ghosh S, Gachhui R, Crooks C, et al: Interaction between caveolin-1 and the reductase domain of endothelial nitric-oxide synthase. Consequences for catalysis. J Biol Chem 273: 22267-22271, 1998. (Pubitemid 28399783)